From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches ...

In the week following the announcement of this acquisition, Sanro Health, Inc. is reported to have made an investment in ...

The lesion characteristics of patients with geographic atrophy (GA) were found to affect the lesion growth rate, with ...

The software includes scattergrams comparing attempted vs achieved corrections, which can be used to refine surgical ...

To celebrate Ophthalmology Times' 50th anniversary, we asked leading experts what the practice would look like today had ...

Oluwatosin U. Smith, MD, reflects on early experiences caring for pediatric patients with complex glaucoma and how evolving ...

Iron dysregulation contributes to oxidative stress, inflammation, and ferroptosis, driving retinal degeneration in dry AMD ...

ONL Therapeutics announced the first patient has been randomized in its phase 2 GALAXY ( NCT06659445) trial evaluating ...

The BIM-IOL system showed a 42% reduction in mean IOP and improved visual acuity, with no serious adverse events linked to ...

Andrew G. Lee, MD, was joined by Drew Carey, MD, for a live recording of the Ophthalmology Times “NeuroOp Guru” during the ...

Broadwood Partners, STAAR's largest shareholder, opposes the Alcon merger, citing board conflicts and rushed decision-making.

David Eichenbaum, MD, FASRS, recalls an early-career case managing bilateral diabetic macular edema with frequent ...